对化学疗法诱导的骨髓瘤瘤微环境重塑的单细胞转录基因洞察
Xuejing Zheng1, Wence Wu2, Zhenguo Zhao1
1Departments of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Nanli, Panjiayuan, Chaoyang District, Beijing, 100021, China.
Journal of cancer research and clinical oncology
|July 20, 2024
概括
在骨髓瘤 (OS) 中的新辅助化疗促进癌症干和改变瘤微环境 (TME). 这种治疗减少了抗瘤免疫细胞,影响治疗效果,并可能导致抗药性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 新辅助化疗是骨髓瘤 (OS) 的标准治疗方法.
- 了解化疗对瘤微环境 (TME) 的影响对于改善治疗结果至关重要.
- 化疗不仅影响癌细胞,还影响瘤内的免疫和 stromal 组件.
研究的目的:
- 研究新辅助化疗对骨髓瘤瘤微环境中的细胞组成和基因表达的影响.
- 在晚期骨髓瘤中鉴定化疗诱导的特定细胞和分子变化.
主要方法:
- 单细胞RNA测序用于分析瘤样本.
- 在接受新辅助化疗之前和之后,从患有晚期骨髓瘤的患者中采集了样本.
主要成果:
- 化疗增加了剩余的骨髓瘤细胞中的干性基因表达.
- 观察到癌症相关纤维细胞的增加,增强了细胞外矩阵 (ECM) 修饰.
- 内皮细胞数量增加,但它们的分化能力受损.
- 免疫细胞种群的显著减少,包括髓状细胞和T/NK细胞,特别是具有抗瘤功能的细胞.
结论:
- 化疗严重改变骨髓瘤TME,影响癌细胞的行为和免疫监测.
- 这些变化提供了关于骨髓瘤治疗耐药性机制的见解.
- 这些发现可能会指导开发针对晚期骨髓瘤的新疗法策略.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


